🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This project aims to evaluate the efficacy and safety of oral taurine suppl...
Status
Unknown
Location
Tang-Du Hospital
Start Date
2023-08-01
Trial ID
NCT06123455
Treatments Being Tested
The purpose of this study is to compare the curative effect of oral S-1 wit...
Status
Unknown
Location
Multiple Locations
Start Date
2018-10-20
Trial ID
NCT03700333
Treatments Being Tested
Gastric cancer is a highly heterogeneous tumor. The most commonly used clin...
Status
Withdrawn
Location
Beijing Cancer Hospital / Peking University Cancer Hospital
Start Date
2021-05-11
Trial ID
NCT04863430
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose and sa...
Status
Unknown
Location
Zhenzhou-Yang
Start Date
2014-11
Trial ID
NCT02277158
Treatments Being Tested
This is a non-randomized, phase II, open label study of apatinib mesylate t...
Status
Completed
Location
Shanghai ninth people's hospital
Start Date
2017-10-01
Trial ID
NCT03267121
Treatments Being Tested
This is a phase II, one-arm study, which is aiming to evaluate the feasibil...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01-01
Trial ID
NCT05627414
Treatments Being Tested
The purpose of this study is to compare the efficacy of S1 plus paclitaxel ...
Status
Unknown
Location
The First Affiliated Hospital of China Medical University
Start Date
2017-11-01
Trial ID
NCT03990103
Treatments Being Tested
This study aims to evaluate the efficacy and safety of HIPEC combined with ...
Status
Not Yet Recruiting
Location
Fourth Affiliated Hospital of Hebei Medical University
Start Date
2025-12-12
Trial ID
NCT07304258
Treatments Being Tested
Comparing S1 generic With Capecitabine in Patients With Metastatic Breast C...
Status
Terminated
Location
Fudan University Cancer Hospital
Start Date
2012-01
Trial ID
NCT01655992
Treatments Being Tested
Based on the FRECO-2 study, Fruquintinib has become one of the standard thi...
Status
Unknown
Location
Sichuan University West China Hospital
Start Date
2023-02-20
Trial ID
NCT06427005
Treatments Being Tested